Site Search
ARCHIVED: NOT AVAILABLE FOR CREDIT
Health Care Developments: Impact on Pathology Practice, and CAP Advocacy Issues
Recent developments in payment models and mechanisms, anti-trust statues in healthcare, and evolving coding procedures all present "threats and opportunities" to the practice of pathology and laboratory medicine. In this session, Drs. Weiss and Miller discuss some of these developments in detail including: Accountable care organizations, strategies for fixing the Sustainable Growth Rate, anatomic pathology CPT code updates for 2015, as well as direct billing, self-referral, and Stark safe harbor donation exemptions. The importance of advocacy on behalf of pathology is emphasized and opportunities and advice for engagement with lawmakers on the national level are also discussed.
Originally published on May 05, 2015
Lecture Presenters
 | Ronald L. Weiss, MD, MBA Staff Hematopathologist |
Dr. Weiss served as ARUP's chief medical officer and director of laboratories from 1993 until 2002, director of business development from 2002 until 2003, president and chief operating officer from 2003 until 2009, and executive vice president from 2009 until 2010. Dr. Weiss is a professor of pathology at the University of Utah and is board certified in anatomic/clinical pathology, microbiology, and hematology by the American Board of Pathology. Dr. Weiss is past chairman of the board of the American Clinical Laboratory Association and past president of the American Pathology Foundation. He is a fellow of the College of American Pathologists and the American Society of Clinical Pathologists. Dr. Weiss received his MD from Creighton University and an MBA from the University of Utah, where he completed his residency training.
 | Dylan Miller, MD Director of the Electron Microscopy and Immunostains Laboratory |
Dr. Dylan Miller ’s specialty expertise includes cardiovascular and renal pathology, with an interest in cardiac transplantation pathology, vasculitis syndromes, aortopathies, and immune-mediated diseases. He is currently president of the Utah Society of Pathologists and has been an active advocate for pathology at the state and national level.
Objectives
After this presentation, participants will be able to:
- Understand anticipated shifts in payment model paradigms affecting pathology and lab services reimbursement (including the ACA, SGR, ACOs, CLFS etc.).
- List specific concerns posing a threat to the practice of pathology and laboratory medicine (including self referral, direct billing, EHR donation etc.).
- Recognize the role of "grass roots" advocacy (and ways to participate) in affecting policies important to the practice of pathology and laboratory medicine.
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories